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Graphene-Iodine Nanocomposites: 
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Human Cells
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Graphene-composites, capable of inhibiting bacterial growth which is also bio-compatible with 
human cells have been highly sought after. Here we report for the first time the preparation of new 
graphene-iodine nano-composites via electrostatic interactions between positively charged graphene 
derivatives and triiodide anions. The resulting composites were characterized by X-ray photoemission 
spectroscopy, UV-spectroscopy, Raman spectroscopy and Scanning electron microscopy. The 
antibacterial potential of these graphene-iodine composites against Klebsiella pneumonia, 
Pseudomonas aeruginosa, Proteus mirobilis, Staphylococcus aureus, and E. coli was investigated. In 
addition, the cytotoxicity of the nanocomposite with human cells [human white blood cells (WBC), 
HeLa, MDA-MB-231, Fibroblast (primary human keratinocyte) and Keratinocyte (immortalized 
fibroblast)], was assessed. DGO (Double-oxidizes graphene oxide) was prepared by the additional 
oxidation of GO (graphene oxide). This generates more oxygen containing functional groups that can 
readily trap more H+, thus generating a positively charged surface area under highly acidic conditions. 
This step allowed bonding with a greater number of anionic triiodides and generated the most potent 
antibacterial agent among graphene-iodine and as-made povidone-iodine (PVP-I) composites also 
exhibited nontoxic to human cells culture. Thus, these nano-composites can be used to inhibit the 
growth of various bacterial species. Importantly, they are also very low-cytotoxic to human cells 
culture.
Graphene is a single-atom-thick sheet of dense honeycomb-arrayed structures composed of sp2-bondedcarbon 
atoms that has attracted enormous amount of interest due to its unique physical properties1. This material can 
be used in many fields including the biomedical field2 as biosensors3, biochips4, diagnostic devices5, implantable 
medical devices (e.g., prostheses)6, drug delivery systems7, and imaging probes8. Both graphene oxide (GO) and 
double oxidized GO (DGO) contain a wide range of reactive oxygen functional groups. These functional groups 
facilitate their use in bioengineering. Graphene derivatives exhibit a low production cost, large surface area, good 
colloidal behavior, and low cytotoxicity. The solubility of graphene derivatives in solvents, especially water, is 
highly important for bioengineering applications. The maximum solubility of these graphene derivatives insol-
vent depends on both solvent polarity and the extent of oxygen group surface functionalization. Previous reports 
have shown that graphene and its derivatives are biocompatible materials that allow the growth of human cells, 
with very limited or non-cytotoxicity9. These unique characteristics of graphene have motivated research groups 
to use these materials in tissue engineering, wound therapy, tissue implants, and drug delivery applications.
Several researchers have reported that graphene derivatives promote the adhesion and proliferation of dif-
ferent type of human cells10–12. One report has revealed that contact with GO reduced the growth of E. coli and 
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Staphylococcus aureus bacterial cells about 51 and 61%, respectively. Similar results were been reported when 
these two microorganisms were exposed to GO nanowalls13. Moreover, graphene oxide film has been reported to 
produce inhibition zones in E. coli and S. aureus14. However, another report by Das et al. found that GO was not 
cytotoxic and lacked any antibacterial effect15. In summary, the numerous conflicting reports about the antimi-
crobial properties of GO.
Ma et al.16 reported that silver-modified graphene oxide nanosheets exhibited antibacterial activity against 
E. coli. Also, Bao et al.14 reported the preparation of a paper-like Ag nanoparticle/GO composite material via the 
in-situ reduction of absorbed Ag+ by hydroquinone (HQ) in a citrate buffer solution. Using a different approach, 
Liu et al.17 reported that Ag nanoparticles anchored on GO composites through a two-phase (toluene-water) 
process. In addition, Tang et al.18 reported that silver nanoparticles anchored on GO exhibited antibacterial prop-
erties against both the Gram-negative bacteria E. coli and the Gram-positive bacteria Staphylococcus aureus 
(S. aureus).
Finally, Ruiz et al. demonstrated that GO does not have inherent antibacterial, bacteriostatic, or cytotoxic 
effects in either bacteria ormammaliancells19. According to them, silver-doped GO films were able to produce 
inhibition zones and induce bacterial cell death; however silver is highly cytotoxic for cell cultures20.
In addition, graphene-PLL composite materials were reported as showing antibacterial effects against E. coli 
bacteria and are biocompatible with human cell cultures21. The antimicrobial activity of PLL against E. coli is well 
established22. Lee et al. were able to attach a greater number of PLL molecules to the graphene surface due its large 
surface area with oxygen functional groups, resulting in a product more potent than PLL alone21.
The iodine complex, which is formed by mixing polyvinylpyrrolidone (PVP) and iodine has been established 
as a way to take advantage of the desirable biocidal properties of iodine, while simultaneously avoiding its irritat-
ing side effects23. Hence, PVP-I has become the most usable attractive product, especially in surgery where it is 
used to coat the skin to prevent infection. Although povidone-iodine is claimed by many to be nonsensitizing and 
nonirritating to human tissue, cases of contact irritation and contact allergic dermatitis to PVP-I formulations 
have also been reported24. PVP is a water soluble polymer, and likewise, the as-made PVP-I complex is also water 
soluble. However, water solubility is undesirable for most of the applications of these formulations. Hence, there 
is a need for more effective and stable composites.
Results
The main objective of this study was to prepare a series of graphene-iodine composites, based on the commer-
cially available povidone-iodine (PVP-I) complex, with potent antibacterial activity. Both GO and DGO are 
known to contain many oxygen functional groups (e.g., hydroxyl, carboxyl, and epoxy groups), which facilitate 
the trapping of H+ ions. This action results in a net positive charge under highly acidic conditions (pH = 1)25. 
Accordingly, positively charged GO and DGO layers could be formed. The total amount of positive charges could 
be increase with increasing H+ ion concentration, assuming that many triiodide anion molecules are efficiently 
attached onto the positively charged GO and DGO surfaces. The surface area of these composites are very large 
compared with that of PVP-I alone; thus, GO-I and DGO-I composites exhibit improved performance com-
pared with PVP-I alone. The improved performance is presumably a result of the large triiodide-containing sur-
face area, which enables the nano-materials to contact multiple bacteria at once. The antibacterial reactivity of 
graphene-iodine composites would be higher than PVP-I alone; the mechanism of reactivity of those composites 
will be very similar to PVP-I23,26. However, the exact mechanism of the release of elemental iodine from the PVP-I 
molecule is not established24. According to previous reports, after iodine is released, it is toxic to microorganisms 
because it can combines irreversibly with tyrosine residues of proteins, interferes with the formation of hydrogen 
bonds by some amino acids and nucleic acids, oxidizes sulfhydryl groups, and reacts with sites of unsaturation 
in lipids24. We assumed that the antibacterial property of the graphene-iodine composites was dominated by 
the diffusion of iodine from those composites26. The growth of bacteria (Klebsiella pneumonia, Pseudomonas 
aeruginosa, Proteus mirobilis, Staphylococcus aureus, and E. coli) in the presence of graphene derivatives and 
their iodine composites was determined by evaluating antimicrobial activity. The biocompatibility of those mate-
rials were evaluated in the presence of human cells [WBCs, HeLa, MDA-MB-231, Fibroblast (primary human 
keratinocyte) and Keratinocyte (immortalized fibroblast)]. One previous report suggested that the SWCNT and 
PVP-I composite showed antibacterial activity against E.coli bacteria27. Presumably novel GO-I and DGO-I com-
posites exhibit improved potent antibacterial activity with a very low-cytotoxic effect on human cells, whereas 
reported GO-Ag has high cytotoxic effect towards bacteria as well as human cells. However, till now no report has 
demonstrated that graphene-iodine composites have intrinsic antibacterial properties and are very low-cytotoxic 
to human cells.
Characterization of Graphene-I Composites. X-ray photoemission spectroscopy (XPS) was used to 
investigate the elemental composition and amount of materials. As-made GO sheets were synthesized from 
graphite powder using a modified Hummer’s method (Bay carbon, SP-2) and were purified as previously 
reported28. As-made DGO sheets were synthesized by a previously reported procedure29. Based on XPS analysis, 
the as-made GO had a low C/O ratio (~2) (Figure S2). The resulting DGO exhibited a low C/O ratio of ~1.2, 
corresponding to an increase in the oxygen content of the DGO nanosheets, indicating that the DGO contained 
the highest amount of oxygen-containing functional groups. The as-made GO-I and DGO-I composites were 
analyzed by XPS. Figure 1a shows the survey spectra of the GO-I, DGO-I and PVP-I; atomic iodine is detected in 
the form of triiodide and pentaiodide. The high-resolution C1s XPS spectrum of the as-made GO-I sheets showed 
a sharp peak at 284.7 eV, which corresponds to C-C bonds of carbon atoms in a conjugated honey-comb lattice. 
Peaks at 286.6, 287.5 and 288.7 eV could be assigned to different C-O bonding configurations (Fig. 1b)28. In com-
parison to the carbon XPS spectra after the doping, we can see the peak appeared at 285.3 eV after the doping that 
corresponds to the energy of the C–I bonds30,31. Similarly, the C1s XPS spectrum of the DGO-I sheets showed a 
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sharp peak at 284.8 eV that also corresponds to C-C bonds of carbon atoms. Peaks at 286.7, 287.6 and 288.6 eV 
could be assigned to different C-O bonding configurations of the sp2 atomic structure of graphite (Fig. 1c)28. We 
also observed a peak appearing at 285.4 eV, after the iodine doping in DGO, which corresponds to the energy of 
the C–I bonds30,31. The C1s peak is observed at 284.7 and 284.8 eV for GO-I and DGO-I, respectively, which is a 
small shift from 284.6 eV (C-C bond in GO and DGO). Figure 1d,e show XPS core-level spectra of I 3d of GO-I 
and DGO-I, respectively. In both cases, two split peaks at 619.4 and 631.93 eV were observed, correspond to I 
3d3/2 and I3d5/2, respectively, which are attributed to the atomic iodine in the GO-I and DGO-I composites30,31. 
As reported, the I 3d peak is different than that of pure iodine molecules (I2) as observed at a binding energy of 
619.9 eV. Thus, I 3d XPS analysis assumes that the iodine atoms are well attached to the graphene surface and not 
pure iodine molecules, indicating an electrostatic interaction between iodine and oxygen functional groups. The 
doped iodine can form a chemical bond with the oxygen functional groups in the GO and DGO structures that 
involves electrostatic interaction. The quantitative analysis of the XPS spectra shows the presence of 12.2% iodine 
in as-made PVP-I, whereas GO-I and DGO-I have 15.3% and 19.1%, respectively. Thus, we concluded that the as 
Figure 1. I (a) XPS survey spectra of DGO-I, GO-I, and PVP-I. C1s spectra of GO-I (b) and DGO-I (c). High-
resolution I 3d spectra of GO-I (d) and DGO-I (e).
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made GO-I and DGO-I contain higher amounts of iodine in comparison to as made PVP-I. The I 3d XPS spectra 
of PVP-I are given in Figure S3.
The presence of triiodide anion in the composites were tested by UV-spectra measurement. The main UV-vis 
absorption peak of GO and DGO appeared at 229.332 and 253 nm, respectively (Fig. 2a,b). In the case of KI-I2 
solution, the absorption peak appeared at 352.2 and a broad peak at 460 nm, in agreement with the reported λ max 
for the triiodide anion33. After the composite formation of triiodide anion with GO, DGO and PVP, we observed 
a small red shift relative to the triiodide anion peak. Specifically, the main absorption peaks of as made GO-I, 
DGO-I and PVP-I appeared in the UV-vis spectra at ~354 and ~465 nm, (~2–5 nm red shifts compared with the 
peak for KI-I2 solution alone), indicating the formation of composites with triiodide anion.
Raman spectroscopy provides a fast and easy structural and quality characterization of the as-made carbon 
materials. Raman spectra were collected from the as-made samples at an excitation wavelength of 514 nm, under 
ambient conditions, by dropping DI-water dispersions on a silicon (Si) substrate. Figure 2c,d show the Raman 
spectra of iodine-doped GO and DGO in comparison to only GO and DGO, respectively. The Raman spectra of 
as-prepared GO and DGO exhibited two remarkable peaks at about ~1353 and ~1600 cm−1, respectively, corre-
sponding to the well-defined D and G bands (Fig. 2c,d). Generally, the G band is related to the E2g-vibration mode 
of sp2 carbon domains and can be used to explain the degree of graphitization. In contrast, the D band is associ-
ated with structural defects and partially disordered structures of the sp2 domains28. In our study, the ID/IG ratio 
of the as-prepared DGO exhibited a significant increase in comparison to the as-made GO. In the case of GO, 
the ID/IG ratio was 0.98 and, after double oxidation, the DGO sample was 1.02 due to two time strong oxidation 
procedure (Fig. 2c,d). The Raman spectroscopy in Fig. 2c,d shows that the D and G peaks of GO-I and DGO-I 
samples did not shift, compared to the GO and DGO samples. But, the ID/IG ratio of GO-I and DGO-I exhibited a 
small increase in comparison to the as-made GO and DGO, respectively. At lower wave numbers, two new Raman 
peaks at 115 and 154 cm−1 were observed for GO-I and DGO-I compared with GO and DGO, which should be 
assigned to I3− and I5−, respectively30,31. On the other hand, no Raman peak was observed corresponding to 
molecular iodine (I2) (181 cm−1), which further negates the possibility of physical accumulation of molecular 
iodine on the as-made material surface31.
Scanning electron microscopy (SEM) analysis was used to observe the surface morphology of different mate-
rials (Fig. 3). We observed a thin and wrinkled GO sheets in the SEM images of GOs (Fig. 3a). The as-made GO-I 
showed different morphology in comparison to only GO (Fig. 3b). The SEM images of DGO revealed a more 
wrinkled morphology compared with that of GO (Fig. 3c). As-made DGO-I also showed different surface mor-
phology in comparison to only DGO (Fig. 3d). We also measured the surface morphology of PVP-I and as made 
only KI-I2 complexes to compare with other composites (Figure S4). To demonstrate the distribution of iodine 
Figure 2. I (a) UV-visible spectroscopy of GO, GO-I, PVP-I, and KI-I. (b) UV-visible spectroscopy of DGO, 
DGO-I, PVP-I, and KI-I. (c) Raman spectra of GO and GO-I. (d) Raman spectra of DGO and DGO-I.
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atoms on the GO-I and DGO-I surface, the element mapping in the selected area is shown in Fig. 3e–l. From the 
element mapping, we clearly observed the uniform distribution of C, O and I atoms in our composites.
The surface area of DGO-I and GO-I were measured ~165 m2g−1 and ~149 m2g–1 respectively, which were 
higher than that of the PVP-I (~12 m2g−1).
Bacterial Proliferation in the Presence of GO, DGO and iodine Composites. To determine the 
antibacterial effect of GO, DGO, GO-I and DGO-I composites, samples containing 5 mL of Luria-Bertani (LB) 
nutrient broth in 20 mL test tubes were incubated with prepared materials to a final concentration of 20 μ g/mL. 
As-made materials were then inoculated with E. coli, Klebsiella pneumonia, Proteus mirabilis, Pseudomonas 
aeruginosa, and Stapylococcus aureus bacterial cells to a 0.01 optical density (OD)19. Antibacterial experiments 
were performed with the same amount of dose of materials 1, 2, 5, and 6 (Figure S1), including PVP-I. The exper-
imental controls were prepared by inoculating five kinds of bacteria to an OD of 0.03 in 5 mL of LB broth, which 
means without any of the composites. We examined the supernatant of the cultures at 3 hour intervals to appraise 
the bacterial growth, without disturbing the precipitate at the bottom of each test tubes. At 3, 6, 9, and 12 h, we 
examined the bacterial growth by measuring the absorbance of supernatant of the cultures at 600 nm. The ODs of 
iodine composites (materials 5 and 6) only did not increase after 3 h, whereas the ODs of PVP-I sample increased 
very little. Whereas the other materials (without iodine composites) significantly increased compared with the 
control samples (i.e., without bacteria). In samples containing PVP-I, the ODs increased after 6 h compared with 
GO-I and DGO-I samples. However, the ODs were still very low in comparison to containing only bacteria sam-
ples. In the case of all bacteria, culture tubes containing GO-I (material 5), and DGO-I (material 6) did not have 
any discriminable difference in ODs in comparison to control samples (Fig. 4). The ODs of PVP-I-containing 
culture tubes increased in comparison to GO-I (material 5), and DGO-I (material 6). Surprisingly, samples con-
taining GO-I (material 5), and DGO-I (material 6) did not show any discriminable difference in ODs (average 
absorbance in the range of 0.00–0.04) after 12 h compared with the control samples. The ODs of GO and DGO 
(without iodine) containing samples gradually increased with time and became saturated, in comparison to con-
trol samples. After ~9 h, samples containing only bacteria appeared to be further turbid and had the highest 
Figure 3. I SEM images of different materials. SEM images of (a) GO, (b) GO-I, (c) DGO, (d) DGO-I,  
(e) Element mapping of GO-I composite: (f) I atoms (g) C atoms (h) O atoms. (i) Element mapping of DGO-I 
composite: (j) I atoms (k) C atoms (l) O atoms. (m) Klebsiella pneumonia bacterial-biofilm-containing DGO 
after 12 h. (n) Pseudomonas aeruginosa bacterial-biofilm-containing DGO after 12 h. (o) Proteus mirobilis 
bacterial-biofilm-containing DGO after 12 h. (p) Staphylococcus aureus bacterial-biofilm-containing DGO 
after 12 h. (q) E.coli bacterial-biofilm-containing DGO after 12 h.
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amount of ODs, which may be represent a saturation point compared with control samples (except samples 
5 and 6).
The plot of ODs shown in Fig. 5 demonstrates that the antibacterial property of GO-I and DGO-I composites 
was higher than that of PVP-I alone. Previous studies have already shown that when a dispersed GO solution is 
added to a media solution, which containing salts, GO aggregates and precipitates out of the suspension due to 
producing low-densityaggregates19,34. The presence of a large amount of cells in biofilms has also been reported, 
indicating that GO has no antibacterial effect when added to liquid media19. After 12 h, bacterial grown experi-
mental DGO and DGO-I samples were analyzed by SEM (Fig. 3, S5). According to the SEM images, the precipi-
tated samples of DGO were covered by a thick bacterial biofilm (Fig. 3m–q) containing a large mass of aggregated 
cells in comparison to the control sample (LB broth and DGO, Fig. 3c), whereas bacterial experiment with DGO-I 
did not show any biofilm formation (Figure S5). According to the experimental results, the antibacterial prop-
erty of DGO-I composites was enough to prevent bacterial growth in LB broth, in comparison to that of PVP-I 
composites. Thus, GO-I and DGO-I composites could act as strong antibacterial agents. The ODs shown in Fig. 5 
represent the antibacterial activity of various iodine composites. The DGO-I composite was the most effective 
inhibitor of bacterial growth and was more potent than the GO-I composite, whereas the GO-I and DGO-I 
composites were both more potent inhibitors than PVP-I. Slowly liberated free iodine, from the iodine complexes 
in solution, kills eukaryotic or prokaryotic cells through iodination of lipids and oxidation of cytoplasmic and 
membrane compounds26. Because triiodide has an anionic charge, it attaches to the positively charged oxygen 
groups of the large surface areas of GO and DGO, via electrostatic interactions. Thus, more cationic oxygen func-
tional groups of graphene nanomaterial with a large surface area can conduct the more attachment of anionic 
triiodide, increasing antibacterial property in comparison to that of PVP-I, which does not have a high surface 
area. We hypothesized that the amount of triiodide anion attached to the GO surface should be less than the 
amount in comparison to that of DGO-I composite, resulting in lower antibacterial property. Indeed, according 
to our experimental results, DGO functionalized with more oxygen functional groups which enabled the more 
triiodide-attached composites, thus producing an improved antibacterial agent (Fig. 5).
Figure 4. I Bacterial growth in four test tubes containing the following components after 9 h: LB, LB-
bacteria, LB-composites, and LB-composites-bacteria. The materials used were GO, DGO, PVP-I, GO-I, 
and DGO-I with bacteria Pseudomonas aeruginosa, Klebsiella pneumonia, Staphylococcus aureus, Proteus 
mirobilis, and E.coli.
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To further evaluate the antibacterial effect of graphene derivative-I composites, we performed a live/dead 
assay with the DGO-I composite. All bacteria were cultured in 1 mL of Luria-Bertani (LB) nutrient broth in 5 mL 
test tubes with OD of 0.1 (~4 × 107 cells). Then all the bacterial cells were incubated for 1 h in presence of DGO-I 
composite with a final concentration of 20 μ g/mL. According to previous reports, SYTO 9 and propidiumiodide 
(PI) dye were used to perform the live/dead assay experiment21. As only living and dead bacteria will be stained 
by SYTO 9 or PI, bacteria can easily be dappled and confined between abiotic particles. The positively charged 
fluorescent label PI can stain only the dead bacterial cells as it unable to pass through the positively charged cell 
membranes of the living cells. In contrast to the fluorescent label PI molecules, the neutral SYTO 9 molecules 
can traverse the cell membrane of both the living and dead cells. However, when dead cells are labelled with a 
mixture of SYTO 9 and PI, the green fluorescence caused by SYTO 9 will be subdued by a fluorescence resonance 
energy transfer (FRET) effect, causing the dead cells to fluoresce in red. It has been reported that the combination 
of SYTO 9 and PI is well suited stain system for eukaryotic cells35. In Figure S6 are presented the staining results 
for all analyzed species. The SYTO 9 and PI overlay images in Figure S6 (1a–5a) clearly show the presence of only 
live cells in control treated samples and Figure S6 (1b–5b) show the presence of only dead cells with composites 
treated samples. The relative average intensities of only dead cells for each condition were calculated to be 3–5% 
and 95–97% for the control and the DGO-I-treated samples, respectively [Figure S6 (1c–5c)]. The experimental 
data were quantified by taking the ratio of the number of dead cells to the total number of cells for both the condi-
tions, the control and the DGO-I treated samples (n = 3). The differences between the percentages for the control 
and the as-made material-treated samples were found to be statistically remarkable using a t test (p < 0.005). 
Accordingly to the live/dead assay experiment, the DGO-I composite had high antibacterial activity on all five 
kinds of bacterial cells.
The antibacterial activities of the GO-I and DGO-I composites were also investigated qualitatively by the disk 
diffusion assay (Fig. 6). First, we coated sterile filter papers with neat, GO, DGO, GO-I, DGO-I, and PVP-I mate-
rials. Filter papers were allowed to dry and were then incubated for 24 h at 37 °C on LB culture plates containing 
each bacterium at a concentration of 1 × 109 cells/mL. Filter paper without any material coating (neat) served as a 
control sample. Bacteria growth was observed with the naked eye in the cases of GO- and DGO-coated, and neat 
filter paper samples with large bacteria colonies (Figure S7). We did not find an inhibition zone in either the GO- 
and DGO-treated samples (Figure S7), or the control sample (Fig. 6), since GO and DGO have no antibacterial 
activity. However, after coating the filter paper with GO-I, DGO-I, and PVP-I composites, the inhibition zones 
were obviously visible. The average zones of inhibition of bacterial growth, as measured in millimetres from the 
edge of the filter paper to the point of uninhibited bacterial growth, were as summarized in Table 1. The diameter 
of the inhibition zone of each bacteria treated with DGO-I is a little bit larger than that treated with GO-I, and 
those are even larger than PVP-I, under the same conditions (Table 1). The inhibition zones are generated due to 
the diffusion of iodine from the graphene-iodine complexes to the agar, rather than to the release of iodine vapor 
above the plate. The differences in the inhibition zones represent the different sensitivities of the organisms to the 
Figure 5. I Graphs showing bacterial growth levels in the supernatant of samples containing prepared 
composites: (a) E. coli, (b) Klebsiella pneumonia, (c) Proteus mirobilis, (d) Pseudomonas aeruginosa, and  
(d) Staphylococcus aureus.
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iodine and also to the different amounts of iodine that diffuse from the various iodine composites. The iodine is 
slowly released from these as-made complexes (Table S1)27.
Cytotoxicity of GO, DGO and iodine Composites on Human Cells. We evaluated the effect of com-
posite (materials 1, 2, 5, 6, and PVP-I) films on human cell attachment and growth using common human WBCs, 
HeLa and MDA-MB-231cell lines22,36,37. Various composites were coated on glass coverslips by spin-casting sam-
ples with 100 μ L of a 1 mg/mL solution21. Only glass coverslips and GO/DGO composite-coated coverslips were 
placed in a culture dish followed by the addition of the cell culture media and different human cells. Cells were 
allowed to attach and grow on the coverslips. Those cells attachment was evaluated by light microscopy at differ-
ent times. Figure 7 and S8 are shown the representative images of different cell morphologies of WBCs, HeLa and 
MDA-MB-231cells after incubation for 24 h. According to the experimental results, the human cells efficiently 
attached to and grew on glass coverslips coated with different composites (Fig. 7b–f). The micrographs of WBCs 
showed marked morphological changes and spreading on coverslips coated with composites in comparison 
to the control glass coverslips (Fig. 7a), which is well known characteristic of effective cell attachment and cell 
growth (Fig. 7). In contrast the control experiments with only glass coverslip, few cells were attached, indicating 
a lack of enlargement and growth of WBC cells (Fig. 7a). These data suggest that the graphene-iodine composites 
(Fig. 7d,e) also allow more efficient growth of human cells in comparison to the as-made PVP-I, which implies 
that these materials are not cytotoxic to human cell culture with a used amount of material. Similar findings were 
observed for HeLa and MDA-MB-231 cells (Figure S8). Taken together, these results indicate that all of the pre-
pared iodine composites are suitable for human cell attachment and growth.
To evaluate and compare the in vitro cytotoxicity of the composites, we analysed the effects of GO, DGO, 
GO-I, DGO-I, and PVP-I on the cell viability of common human WBCs, HeLa and MDA-MB-231cell lines. As 
expected, cell viability were greater than ~98% for GO and DGO was as high as 100 μ g mL−1 for all cell lines, 
indicating that the graphene derivatives were biocompatible (Fig. 7g, S8)38. As depicted in Figure 7g and S8, no 
noticeable amount of cells were observed by as-made GO-I, DGO-I at the high concentration of 100 μ g mL−1. 
Moreover, PVP-I also exhibited a biocompatibility at the same condition. Therefore, we can conclude that our as 
Figure 6. I Photographs of the inhibition zone by the disk diffusion assay of E. coli, Klebsiella pneumonia, 
Pseudomonas aeruginosa, Proteus mirobilis, and Staphylococcus aureus bacteria with neat, PVP-I, GO-I, 
and DGO-I coated filter paper. 
Bacteria Name
Inhibition 
zone with 
GO (mm)
Inhibition 
zone with 
DGO (mm)
Inhibition 
zone with 
PVP-I (mm)
Inhibition 
zone with 
GO-I (mm)
Inhibition zone with 
DGO-I (mm)
Klebsiella pneumoniae – – 19.1 25.8 35.1
Proteus mirabilis – – 18.2 23.2 32.6
Pseudomonas aeruginosa – – 21.4 28.8 35.9
Stapylococcus aureus – – 21.1 26.1 32.2
E. Coli – – 23.6 28.8 36.1
Table 1.  I Inhibition zone on solid LB plate by the treatment with different composites.
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made GO-I and DGO-I derivatives are non-cytotoxic to human cells. We have also analyzed the cytotoxicity test 
(EZ-CYTOX assay) and the IL-8 release (ELISA) for our as-made nanomaterials for human skin cells [Fibroblast 
(primary human keratinocyte), Keratinocyte (immortalized fibroblast)] (Fig. 8). Actually, EZ-cytox assay was 
also performed with PVP-I treated cultures. However, the absorbance from the PVP-I treated cultures superna-
tants did not reflect cell viabilities because PVP-I still remained in the supernatants even after centrifugation at 
12,000 g. In case of EZ-CYTOX we have observed that our as-made nanomaterials are very low toxic.
Discussion
This was a comprehensive study of antibacterial effects of triiodide molecule onto the graphene (GO and DGO) 
surface based on their number of oxygen containing functional groups. GO-I, DGO-I composites were pre-
pared by the interactions between iodine and the number of oxygen containing functional groups of respective 
graphene materials. The antibacterial potency increases as the number of oxygen containing functional groups 
on graphene derivatives increase. This increase is due to the resultant large surface area, which can undergo 
extensive iodine interactions via electrostatic interaction, thereby generating graphene-iodine composites (GO-I 
and DGO-I). Therefore, this is the first report to show graphene-iodine composites can be highly effective anti-
bacterial agents with very low-cytotoxic effects for human cell cultures. The most effective part is that DGO-I 
composites, featured the highest antibacterial activity ever reported with biocompatible for human cells cultures. 
Our graphene and iodine composites are easy to fabricate, contained higher amounts of iodine, and exhibited 
superior antibacterial activity compared with to as-made PVP-I at the same doses.
In summary, this study demonstrates that graphene alone has no antibacterial properties, which is consist-
ent with previous reports. We synthesized novel graphene-iodine composites via the electrostatic interactions 
between triiodide anions and GO and DGO derivatives synthesized to have positively charged oxygen functional 
groups. The triiodide generated a larger iodine source on DGO-I composites. As a result, DGO-I composites 
Figure 7. I Growth of Human white blood cells on (a) glass coverslips, (b) GO, (c) DGO, (d) GO-I, (e) DGO-
I, and (f) PVP-I (20×). (g) In vitro concentration-dependent (100, 50, 25, 12.5, and 6.125 μ g/mL, respectively 
from left to right) cell viability of WBCs. The cells were incubated with free GO, DGO, GO-I, DGO-I, and PVP-I 
for 24 h as indicated. Data represent mean ± Standard Error of the Mean (SEM)(n = 6)(***p < 0.05 versus PBS, 
one-way ANOVA).
Figure 8. I The IL-8 release (ELISA) (a) and the cytotoxicity test (EZ-CYTOX assay) (b) for as-made GO, 
DGO, GO-I, DGO-I, and PVP-I with different concentration (6.125, 12.5, 25, 50, and 100 μ g/mL, respectively 
from left to right) for human skin cells [Fibroblast (primary human keratinocyte), Keratinocyte (immortalized 
fibroblast)].
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exhibited the most potent antibacterial activity compared to the other compounds in the study. Applications 
of iodine composites were explored by fabricating antibacterial materials that can be act as a bacterial growth 
inhibitor. In addition, GO-I and DGO-I composites were shown to be biocompatible for different human cell 
cultures. This is the first report demonstrating that graphene-iodine composites can provide potent bacterial 
growth inhibitor activity with very low-cytotoxic to human cells. The results of this study thus provide insight into 
the biological properties of iodine nano-composites and indicate their potential biomedical and biotechnological 
applications.
Methods
Preparation of Graphene Oxides (GOs). GO sheets were prepared from natural graphite powder using 
the modified Hummer’s method with sulfuric acid, potassium permanganate, and sodium nitrate28.
Synthesis of Double Oxidized Graphene Oxide (DGO). DGO sheets were synthesized by the reported 
procedure from our prepared GO29.
Synthesis of PVP-I Composite. 200 mg of KI and 100 mg of I2 were mixed with 6 mL of DI-water and soni-
cated for 30 min, followed by the addition of 185 mg of PVP. The resulting complex was centrifuged at 14,000 rpm 
for 20 min, washed three times with benzene, and the resulting pellet was dried under vacuum26.
Synthesis of GO-I, and DGO-I Composites. GO and DGO nanosheets were dispersed in deionized 
distilled water (~10 mg/mL), then the solution was adjusted to ~pH 1, and finally mixed with as-made KI-I2 
solution and sonicated for 1h. The resultant solutions were stirred at ~60 °C for 1 h followed by centrifugation at 
14,000 rpm for 20 min, washed three times with benzene, and the resulting pellet was dried under vacuum.
Bacterial Cell Culture. Klebsiella pneumonia (strain MRKP), Pseudomonas aeruginosa (strain PA14), 
Proteus mirobilis (strain PR03), Staphylococcus aureus (strain RN4220), and Escherichia coli (strain DH5R), 
were grown alone, and with different composites, in Luria-Bertani (LB) broth in 20 mL test tubes and incubated 
for 12 h at 37 °C to a final concentration of 20 μ g/mL19.
Bacterial Growth on a Solid Surface. The sterile filter papers were dipped into GO, DGO, GO-I, DGO-I, 
and PVP-I solution (1 mg/mL) and allowed to dry in a vacuum. The resulting filter papers were then placed on a 
sterile LB culture plate coated with bacteria solution containing 1 × 109 cells/mL, and incubated for 24 h at 37 °C19.
Live/dead assay. Bacteria samples containing 1 mL of Luria-Bertani (LB) nutrient broth in 5 mL test tubes 
were incubated for 1 h with DGO-I composites to a final concentration of 20 μ g/mL. The initial OD of the bacte-
rial solution was 0.1 (4 × 107 cells). After that, a Live/Dead Bac-Light Bacterial Viability Kit (L-7007, Molecular 
Probes) was used to label bacterial cells. The staining procedure was followed according to the protocol pro-
vided by Molecular Probes (MP07007). Live bacteria fluoresce green (SYTO 9) and dead bacteria fluoresce red 
(propidium iodide)21. WBC cell line (jurkat cell) and breast cancer cell lines (HeLa Cell, MDA-MB-231 Cell) were 
cultured on plate at 37 °C under 5% CO2 with various concentrations (from 6.125, 50, 100, 500, and 1000 μ g/mL) 
of 1, 2, 3, 4, 5, 6 and 7 by diluted with DI. The viability of cells on the seven materials was estimated after 24 h. 
Following incubation, the adherent cells were detached from the culture plate with trypsin, and counted. Cell 
death was analyzed by trypan blue dye (Sigma Aldrich, Germany) on cell lines. Equal amounts of cell suspension 
and trypan blue were mixed and this was analyzed under a microscope. The cells which were viable excluded the 
dye and were colorless while those whose cell membrane was destroyed were blue. Viable and dead cells were 
quantified by fluorescence microscopy. The concentrations of cells were measured using a hemocytometer36,37.
Cell Culture. We used a human T-cell lymphoblast-like cell line (Jurkat cells). The cells were cultured in 
RPMI 1640 medium (Gibco) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin and strep-
tomycin (PS). These cells were incubated at 37 °C with 5% CO2. The medium was changed every two days. For 
experiments, 1.5 × 105 cells were seeded in a culture dish containing the glass slides. After 24 h, the morphology 
of cell growth was observed under a microscope39. As common cancer cell lines, we used HeLa Cell Line human 
epitheloid cervix carcinoma (HeLa Cell Line) and human human breast adenocarcinoma (MDA-MB-231 Cell 
Line). The cells were cultured in RPMI 1640 medium (Gibco) supplemented with 10% fetal bovine serum (FBS) 
and 1% penicillin and streptomycin (PS). These cells were incubated at 37 °C with 5% CO2. The medium was 
changed every two days. In case of cancer cell lines, we detached from the plate by trypsin treatment because these 
two cell lines are adhensive cell line. For experiments, 1.5 × 105 cells were seeded in a culture dish containing the 
glass slides. Adhensive cell lines were allowed to attach and develop on the slides. After 24 h, the morphology of 
cell growth was observed under a microscope36,37.
Cytotoxicity Assay. WBCs were seeded into a 48-well cell-culture plate at 37 °C under 5% CO2 with various 
concentrations (6.125, 12.5, 25, 50, and 100 μ g/mL) of solutions 1, 2, 5, 6 and PVP-I, diluted with DI. The via-
bility of cells on the seven materials was estimated after 24 h. Cell death was analyzed by trypan blue dye (Sigma 
Aldrich, Germany) on the Jurkat cell line. Following incubation, equal amounts of cell suspension and trypan 
blue were mixed and this was analyzed under a microscope. The cells that were viable excluded the dye and were 
colorless, while those whose cell membranes were destroyed turned blue. Viable and dead cells were quantified 
by fluorescence microscopy. The concentrations of cells were measured using a hemocytometer. All experiments 
were performed under the same conditions, and the relative cell viability (%) was expressed as a percentage rela-
tive to the untreated control cells40.
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Cell culture. Primary human epidermal keratinocytes (Lonza, Basel, Switzerland) were cultured in 
KGM-Gold™ Keratinocyte Growth Medium supplemented with KGM-Gold SingleQuot Kit (Lonza, Basel, 
Switzerland). BJ-5ta human fibroblasts (ATCC, VA, USA) were cultured in DMEM (Lonza, Basel, Switzerland) 
supplemented with 10% heat inactivated fatal bovine serum (Corning, NY, USA) penicillin (100 U/ml) (GIBCO, 
MA, USA) and streptomycin (0.1 mg/ml) (GIBCO, MA, USA)41.
Cytotoxicity test. Cytotoxicity of various graphene-iodine nanocomposites (GO, GO-1, DGO, DGO-1, 
PVP-1) were assessed on immortalized human fibroblasts using EZ-cytox assay (Daeillab service, Seoul, Korea). 
Fibroblasts at passage 9 were seeded into the wells of a 96-well plate (Costar, IL, USA) at a density of 1 × 104 
cells per well in 50 μ L of phenol-red free DMEM culture medium. On the other hand, nano-material solutions 
at various concentrations (200, 100, 50, 25, and 12.5 μ g/mL) were freshly prepared by diluting 1 mg/mL stock 
solutions of various nano-materials with the culture medium. To obtain well-dispersed nano-material suspen-
sions, all the stock and the diluted solutions were sonicated for 30 min before using. After 12 h of seeding the cells, 
50 μ L of the nano-material solutions were added to each well in which their final concentrations were 100, 50, 
25, 12.5, or 6.25 μ g/mL. The cells were cultured with the nano-materials for 20 h and 10 μ L EZ-cytox solution was 
added to each well. Then, the cells were incubated for a further 4 h to allow the color of the culture supernatants 
to be changed by reaction between viable cells and EZ-cytox solution. After the reaction, nano-material-free 
supernatants were obtained by spinning down nano-materials with 12,000 g. The nano-material-free super-
natants were transferred to a fresh 96-well plate and absorbance was read at 450 nm to determine cell viabil-
ity of each well. Finally, the cell viabilities of nano-material-treated cultures were expressed as percentages of 
nano-material-untreated control cultures41.
Cytokine release assay_IL-8 ELISA. Human primary keratinocytes at passage 5 were seeded into the wells 
of a 24-well plate (Costar, IL, USA) at a density of 5 × 104 cells per well in 500 μ L of culture medium. On the other 
hand, nano-material solutions at various concentrations (200, 100, 50, 25, and 12.5 μ g/mL) were freshly prepared 
by diluting 1 mg/mL stock solutions of various nano-materials with culture medium. To obtain well-dispersed 
nanomaterials suspension, all the stock and the diluted solutions were sonicated for 30 min before using. After 
12 h of seeing the cells, 500 μ L of the nano-material solutions were added to each well in which their final concen-
trations were 100, 50, 25, 12.5, or 6.25 μ g/mL. After incubation of the cells the nano-materials for 24 h, the culture 
supernatants were collected to analyze amounts of IL-8 released from the cells using ELISA. Prior to ELISA test, 
nano-materials in supernatants were spun down at 12,000 g to reduce potential interference in antibody reaction 
by nanomaterials. The Assay was performed using a commercial —ELISA kit (Thermo Fisher scientific Pierce, IL, 
USA), following manufacturer’s instructions41–43.
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